Klaviyo, Inc.

For the period ended Jun 30, 2025. Filed Aug 5, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 5, 2025

KVYO$20.43-1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheets (Unaudited)

	As of,
	June 30, 2025	December 31, 2024
Assets
Current assets:
Cash and cash equivalents	$935,516	$881,473
Restricted cash	—	375
Accounts receivable, net of allowance for doubtful accounts	58,843	43,095
Deferred contract acquisition costs, current	25,070	20,544
Prepaid expenses and other current assets	41,642	34,262
Total current assets	1,061,071	979,749
Property and equipment, net	56,677	48,200
Right-of-use assets, net	86,592	42,917
Deferred contract acquisition costs, non-current	36,799	32,527
Restricted cash, non-current	738	739
Prepaid marketing expense	143,098	153,346
Other non-current assets	12,907	15,830
Total assets	$1,397,882	$1,273,308
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$22,879	$14,579
Accrued expenses	89,563	99,828
Lease liabilities, current	19,086	20,989
Deferred revenue	82,711	64,497
Total current liabilities	214,239	199,893
Lease liabilities, non-current	80,101	32,449
Other non-current liabilities	6,790	6,979
Total liabilities	301,130	239,321
Stockholders’ Equity
Preferred stock: $0.001 par value; 100,000,000 shares authorized; 0 and 0 shares issued and outstanding at June 30, 2025, and December 31, 2024, respectively.	—	—
Series A common stock: $0.001 par value; 3,000,000,000 shares authorized; 116,877,930 and 88,956,301 shares issued and outstanding at June 30, 2025, and December 31, 2024, respectively.	117	89
Series B common stock: $0.001 par value; 350,000,000 shares authorized; 182,757,254 and 183,801,332 shares issued and outstanding at June 30, 2025, and December 31, 2024, respectively.	183	184
Additional paid-in capital	1,980,007	1,878,899
Accumulated deficit	(883,555)	(845,185)
Total stockholders’ equity	1,096,752	1,033,987
Total liabilities and stockholders’ equity	$1,397,882	$1,273,308

The accompanying notes are an integral part of these condensed consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.